Oxaliplatin and 5-fluorouracil in heavily pretreated patients with ovarian carcinoma: A well tolerated and efficient treatment

被引：0
|
作者：
Rosa, D. D. [1 ]
Awada, A. [1 ]
Cardoso, F. [1 ]
Gil, T. [1 ]
Lebrun, F. [1 ]
Mano, M. S. [1 ]
Selleslags, J. [1 ]
Piccart, M. J. [1 ]
D'Hondt, V. [1 ]
机构：
[1] Jules Bordet Inst, Brussels, Belgium
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
16028
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Oxaliplatin/5fluorouracil-based chemotherapy was active and well tolerated in heavily pretreated patients with ovarian carcinoma
    Rosa, Daniela D.
    Awada, Ahmad
    Mano, Max S.
    Selleslags, Jean
    Lebrun, Fabienne
    Gil, Thierry
    Piccart, Martine J.
    D'Hondt, Veronique
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2008, 278 (05) : 457 - 462
  • [2] Oxaliplatin/5fluorouracil-based chemotherapy was active and well tolerated in heavily pretreated patients with ovarian carcinoma
    Daniela D. Rosa
    Ahmad Awada
    Max S. Mano
    Jean Selleslags
    Fabienne Lebrun
    Thierry Gil
    Martine J. Piccart
    Véronique D’Hondt
    Archives of Gynecology and Obstetrics, 2008, 278 : 457 - 462
  • [3] Feasibility of Oxaliplatin, Leucovorin, and 5-Fluorouracil (FOLFOX-4) Chemotherapy in Heavily Pretreated Patients with Recurrent Epithelial Ovarian Cancer
    Lee, Hee Jun
    Kim, Hee Seung
    Park, Noh Hyun
    Chung, Hyun Hoon
    Kim, Jae Weon
    Song, Yong Sang
    CANCER RESEARCH AND TREATMENT, 2013, 45 (01): : 40 - 47
  • [4] Combination of irinotecan, oxaliplatin and 5-fluorouracil as a rechallenge regimen for heavily pretreated metastatic colorectal cancer patients
    Fernandes G.D.S.
    Braghiroli M.I.
    Artioli M.
    Paterlini A.C.C.R.
    Teixeira M.C.
    Gumz B.P.
    Girardi D.M.
    Braghiroli O.F.M.
    Costa F.P.
    Hoff P.M.
    Journal of Gastrointestinal Cancer, 2018, 49 (4) : 470 - 475
  • [5] Oxaliplatin and protracted continuous 5-fluorouracil infusion in patients with pretreated advanced colorectal carcinoma
    Martoni, A
    Mini, E
    Pinto, C
    Nobili, S
    Gentile, AL
    Dentico, P
    Angelelli, B
    Scicolone, S
    Piana, E
    Mazzei, T
    ANNALS OF ONCOLOGY, 2001, 12 (04) : 519 - 524
  • [6] Compassionate-use oxaliplatin with bolus 5-fluorouracil/leucovorin in heavily pretreated patients with advanced colorectal cancer
    LaRocca, RV
    Glisson, SD
    Hargis, JB
    Kosfeld, RE
    Leaton, KE
    Hicks, RM
    Amin-Zimmerman, F
    SOUTHERN MEDICAL JOURNAL, 2004, 97 (09) : 831 - 835
  • [7] Phase II study of oxaliplatin plus leucovorin and 5-fluorouracil in heavily pretreated metastatic breast cancer patients
    Sun, Si
    Wang, Lei Ping
    Zhang, Jian
    Yang, Xiao Yan
    Zhang, Qun Ling
    Jia, Zhen
    Hu, Xi Chun
    Wang, Bi Yun
    MEDICAL ONCOLOGY, 2012, 29 (02) : 418 - 424
  • [8] Phase II study of oxaliplatin plus leucovorin and 5-fluorouracil in heavily pretreated metastatic breast cancer patients
    Si Sun
    Lei Ping Wang
    Jian Zhang
    Xiao Yan Yang
    Qun Ling Zhang
    Zhen Jia
    Xi Chun Hu
    Bi Yun Wang
    Medical Oncology, 2012, 29 : 418 - 424
  • [9] Oxaliplatin and 5-fluorouracil for heavily pretreated metastatic breast cancer:: a preliminary phase II study
    Thuss-Patience, PC
    von Minckwitz, G
    Kretzschmar, A
    Loibl, S
    Schaller, G
    Dörken, B
    Reichardt, P
    ANTI-CANCER DRUGS, 2003, 14 (07) : 549 - 553
  • [10] Oxaliplatin and protracted venous infusion of 5-fluorouracil in patients with advanced or relapsed 5-fluorouracil pretreated colorectal cancer
    I Chau
    A Webb
    D Cunningham
    M Hill
    J S Waters
    A Norman
    A Massey
    British Journal of Cancer, 2001, 85 : 1258 - 1264
12345